24.03.2025 • NewsOMVinvestmentPlastics Recycling

OMV Opens Plant for Plastic Recycling

OMV has announced the expansion of its innovative ReOil technology at the Schwechat refinery near Vienna.

OMV’s new plant can process up to 16,000 metric tons of hard-to-recycle mixed plastic waste annually - equivalent to the annual plastic waste generated by 160,000 Austrian households. 

“The essential materials of the future need to become more sustainable and circular," commented Alfred Stern, Chairman of the Executive Board and CEO of OMV. "OMV’s chemical recycling technology plays a pivotal role in driving growth in our Chemicals segment. The start-up of the new ReOil plant marks a significant milestone on our path towards achieving climate neutrality by 2050 at the latest. Complementing mechanical recycling, ReOil processes plastic waste that would otherwise remain unrecyclable, reintegrating it into the value chain. Through our Strategy 2030, we are advancing circularity as a cornerstone of our responsible transformation.”

ReOil, developed by OMV in 2009, aims to enhance the sustainability of plastics by reintegrating valuable resources into the value chain and avoiding disposal through incineration or landfill. The technology transforms post-consumer mixed plastic waste into pyrolysis oil, which is used to produce sustainable base chemicals. These chemicals are then converted into everyday applications such as food packaging, healthcare products, and components for electric vehicles. By 2030, ReOil is expected to achieve a 34 percent reduction in CO2 emissions if post-consumer mixed plastic waste is chemically recycled instead of incinerated.

The ReOil pilot plant at the OMV Schwechat refinery has been operational since 2018, achieving nearly 30,000 cracking hours and processing over 2.1 million kilograms of plastic waste sustainably. The success of the pilot plant led to the construction of a larger facility, which OMV has now completed and started. Both ReOil plants are ISCC PLUS certified.

OMV is now developing a full-scale industrial plant for chemical recycling, pending internal approvals. On March 12, 2025, OMV secured up to €81.6 million in EU funding for this industrial ReOil plant, the largest public grant ever awarded to the OMV Group.

Company

Logo:

OMV Aktiengesellschaft


Vienna
Austria

Company contact







Artificial Intelligence

Pierre Racz: "Real Artificial Intelligence Does Not Exist"
part one of a three-part interview series

Pierre Racz: "Real Artificial Intelligence Does Not Exist"

In part one Pierre Racz, President of Genetec, is addressing why IP network video systems were the game changer in the industry and why he does not like the term AI.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences

The Start-up Platform for Chemistry & Life Sciences

The tasks range from employee protection, site security and crisis management to IT, OT and production security.

most read

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
24.01.2025 • News

CEFIC Publishes 2024 Facts and Figures Report

CEFIC , the European Chemical Industry Council, has published its 2024 Facts & Figures report, which reinforces the need to take bold and urgent action to secure Europe’s industrial future, not only to implement the Green Deal but also to prevent further de-industrialization in Europe.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.